EXUMA BIOTECH CORP.
WEST PALM BEACH, FLORIDA

EXUMA BIOTECH CORP., originally known as F1 ONCOLOGY, INC., is a pioneering biotechnology company dedicated to advancing cancer treatment through innovative therapies. Established on November 25, 2015, and incorporated in Florida with its headquarters in West Palm Beach, EXUMA BIOTECH CORP. focuses on harnessing the immune system's potential via CAR-T cell therapy for tackling challenging solid tumor malignancies. This endeavor is bolstered by a strategic partnership with BioAtla, aiming to propel CAR-T technology into new therapeutic territories. Operating internationally across multiple time zones including Shanghai, San Diego, West Palm Beach, and Grand Cayman, the company emphasizes the relentless pursuit of data-driven advancements that mirror its commitment against cancer, which 'never sleeps.' EXUMA BIOTECH CORP. is a rapidly-growing global startup eager to attract entrepreneurially-minded and ambitious individuals who are passionate about making significant contributions to the fight against cancer. The company holds the Florida model DOS Florida Company Status with registration details including a filing number of F15000005287, being a Foreign Organization for Profit (FORP). Its last name change event took place on September 29, 2020. The official mailing address is 625 N. Flagler Drive, Suite 625, West Palm Beach, FL, and contact can be made via provided phone numbers. Overseeing the company's strategic direction is Gregory I Frost serving as Chief Executive Officer.